Cardio IQ® Omega-3 and -6 Fatty AcidsMain Content
Test Code: 91734
Methodology: Chromatography/Mass Spectrometry
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute, San Juan Capistrano, CA. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Includes: Omega-3 (EPA+DHA) Index, Omega-6/Omega-3 Ratio, EPA/Arachidonic Acid Ratio, Arachidonic Acid, EPA, DHA
1. Baseline and monitoring of individuals with known CVD (acute and chronic) to determine Rx and compliance.
2. Identify patients with known CVD risk with low omega-3 levels who may be candidates for supplementation/therapy.
3. Monitor patients on omega-3 supplementation/therapy to determine efficacy of treatment.
4. Potential role in risk reduction for non-CVD outcomes-aged related macular degeneration, RA, cancer, etc. (early data).
Alternative Name(s): CardioIQ®,Omega-3 and -6 Fatty Acids, Cardio IQ®
Supply: T02 - Lavender 4mL Blood Tube
Preferred Specimen: Whole Blood
Preferred Volume: 4mL
Transport Container: EDTA Lavender-top 4mL tube
Transport Temperature: Refrigerated (cold-packs)
Specimen Stability: Refrigerated: 14 days
Special Instructions: Overnight fasting is required
Reject Criteria: Grossly icteric; plasma not collected in EDTA tubes; Serum separator tubes
For additional test, supply, or collection device information, please contact DLO's Customer Service at (800) 891-2917, option 2.